Clinical Trial Information Request for Protocol 20-364 Title A Phase 2 study of ruxolitinib in low-risk essential thrombocythemia and polycythemia vera with significant symptom burden PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone